BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3542364)

  • 1. Modulation of the immune response by anaphylatoxins.
    Morgan EL
    Complement; 1986; 3(3):128-36. PubMed ID: 3542364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anaphylatoxin-mediated regulation of human and murine immune responses.
    Morgan EL; Weigle WO; Hugli TE
    Fed Proc; 1984 Jul; 43(10):2543-7. PubMed ID: 6610569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response by anaphylatoxin in the microenvironment of the interacting cells.
    Weigle WO; Morgan EL; Goodman MG; Chenoweth DE; Hugli TE
    Fed Proc; 1982 Dec; 41(14):3099-103. PubMed ID: 6216123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on biological activities of various anaphylatoxins (C4a, C3a, C5a). Investigations on their ability to induce platelet secretion.
    Meuer S; Hugli TE; Andreatta RH; Hadding U; Bitter-Suermann D
    Inflammation; 1981 Dec; 5(4):263-73. PubMed ID: 6976935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of humoral immune responses by synthetic C3a peptides.
    Morgan EL; Weigle WO; Erickson BW; Fok KF; Hugli TE
    J Immunol; 1983 Nov; 131(5):2258-61. PubMed ID: 6355293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of glucose and lactate output and decrease of flow by human anaphylatoxin C3a but not C5a in perfused rat liver.
    Püschel GP; Oppermann M; Muschol W; Götze O; Jungermann K
    FEBS Lett; 1989 Jan; 243(1):83-7. PubMed ID: 2784112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of human anaphylatoxins on guinea pig atria.
    Huey R; Bloor CM; Hugli TE
    Immunopharmacology; 1984 Dec; 8(3-4):147-54. PubMed ID: 6335143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anaphylatoxin-mediated regulation of the immune response. I. C3a-mediated suppression of human and murine humoral immune responses.
    Morgan EL; Weigle WO; Hugli TE
    J Exp Med; 1982 May; 155(5):1412-26. PubMed ID: 6978374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of the anaphylatoxins.
    Hugli TE
    Springer Semin Immunopathol; 1984; 7(2-3):193-219. PubMed ID: 6387982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunopharmacology of anaphylatoxin-induced bronchoconstrictor responses.
    Stimler-Gerard NP
    Complement; 1986; 3(3):137-51. PubMed ID: 3026723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaphylatoxins inhibit C2 production.
    Lappin D; Damerau B; Whaley K
    Clin Exp Immunol; 1983 Nov; 54(2):455-60. PubMed ID: 6317240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioactive complement fragments in immunoregulation.
    Morgan EL; Thoman ML; Hoeprich PD; Hugli TE
    Immunol Lett; 1985; 9(4):207-13. PubMed ID: 3873407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of C3a and C5a anaphylatoxins on guinea-pig isolated blood vessels.
    Marceau F; Hugli TE
    J Pharmacol Exp Ther; 1984 Sep; 230(3):749-54. PubMed ID: 6332191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaphylatoxin-induced neutrophil chemotaxis and aggregation. Limited aggregation and specific desensitization induced by human C3a and synthetic C3a octapeptides.
    Nagata S; Glovsky MM; Kunkel SL
    Int Arch Allergy Appl Immunol; 1987; 82(1):4-9. PubMed ID: 3492446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac anaphylaxis. Complement activation as an amplification system.
    del Balzo U; Polley MJ; Levi R
    Circ Res; 1989 Sep; 65(3):847-57. PubMed ID: 2475275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of complement in the immune response.
    Feldbush TL; Hobbs MV; Severson CD; Ballas ZK; Weiler JM
    Fed Proc; 1984 Jul; 43(10):2548-52. PubMed ID: 6610570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement activation during systemic lupus erythematosus. C3a and C5a anaphylatoxins circulate during exacerbations of disease.
    Belmont HM; Hopkins P; Edelson HS; Kaplan HB; Ludewig R; Weissmann G; Abramson S
    Arthritis Rheum; 1986 Sep; 29(9):1085-9. PubMed ID: 3489467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of leukocyte regulation by complement-derived factors.
    Hugli TE; Morgan EL
    Contemp Top Immunobiol; 1984; 14():109-53. PubMed ID: 6331985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaphylatoxins: possible roles in disease.
    Vogt W
    Complement; 1986; 3(3):177-88. PubMed ID: 3026724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin).
    Sorgenfrei J; Damerau B; Vogt W
    Agents Actions; 1982 Apr; 12(1-2):118-21. PubMed ID: 6177210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.